Press Releases Devonian Health Group Inc.

Equities

GSD

CA2518341078

Market Closed - Toronto S.E. Other stock markets 10:57:57 2024-05-01 am EDT			5-day change	1st Jan Change
0.25 ^CAD	+13.64%		+13.64%	+72.41%

Mar. 28	Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
Mar. 14	Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Devonian Announces Closing of a Private Placement of Units	Mar. 15	AQ
DEVONIAN HEALTH NAMES KATHRYN J. GREGORY TO THE BOARD OF DIRECTORS AND GRANTS STOCK OPTIONS	Mar. 01	AQ
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole in Canada	Feb. 28	AQ
DEVONIAN BOLSTERS INTELLECTUAL PROPERTY WITH ISSUANCE OF U.S. PATENT COVERING A METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE	Feb. 21	AQ
DEVONIAN BOLSTERS LEADERSHIP TEAM AND ALIGNS STRATEGY TO ACCELERATE CLINICAL DEVELOPMENT AND DRIVE REVENUE GROWTH AND COMMERCIAL SUCCESS	Dec. 05	AQ
Devonian Health Group receives a Notice of Allowance for Issuance of a U.S. Patent on a method of treatment of Inflammatory Bowel Disease	23-06-21	AQ
Devonian Health Group announces presentation of Thykamine efficacy results in Atopic Dermatitis at the World Congress of Dermatology and provides Thykamine Clinical Development Program Update	23-05-17	AQ
DEVONIAN HEALTH GROUP ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBERS AND GRANT OF STOCK OPTIONS	23-05-15	AQ
Devonian Announces Filing of Preliminary Base Shelf Prospectus	23-05-12	AQ
DEVONIAN HEALTH GROUP INC. TO PARTICIPATE IN THREE RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES	22-10-25	AQ
DEVONIAN TO PRESENT THYKAMINE PHASE 2 CLINICAL RESULTS AT THE 6th DERMATOLOGY DRUG DEVELOPMENT SUMMIT FOR IINFLAMMATORY SKIN DISEASES	22-10-13	AQ
Devonian Health : Condensed Consolidated Interim Filings for the period ended April 30, 2022	22-06-22	PU
Devonian Health : MD&A for the period ended April 30, 2022	22-06-22	PU
Devonian Health : Certification of Interim Filings - CEO	22-03-31	PU
DEVONIAN HEALTH GROUP ANNOUNCES TRADING ON THE OTCQB MARKET UNDER SYMBOL DVHGF	22-03-11	AQ
DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS	22-03-08	AQ
DEVONIAN HEALTH GROUP ANNOUNCES VOTING RESULTS OF THE ANNUAL GENERAL AND SPECIAL MEETING AND WELCOME NEW BOARD MEMBERS	22-03-02	AQ
DEVONIAN ANNOUNCES ADOPTION OF SHAREHOLDER RIGHTS PLAN AND MODIFICATION TO A PRIVATE PLACEMENT	22-01-28	AQ
DEVONIAN HEALTH GROUP ANNOUNCES APPLICATION FOR OTCQB LISTING	22-01-12	AQ
DEVONIAN HEALTH GROUP ANNOUNCES PUBLICATION OF ARTICLE ON POTENTIAL USE OF THYKAMINE IN THE TREATMENT OF COVID-19 IN THE INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES	21-12-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Devonian Health Group Inc.

Equities

GSD

CA2518341078

Press Releases

Filters